Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | ARWR | ABVX | ||
| Company | Biomarin Pharmaceuticals | Arrowhead Pharma | Abivax Sa ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.04 | 75.55 | 125.00 | ||
| High | 55.05 | 76.51 | 125.64 | ||
| Low | 53.56 | 74.53 | 120.05 | ||
| Latest | 54.09 | 74.95 | 121.99 | ||
| Change | -0.01 | -0.59 | -2.04 | ||
| % Change | -0.02% | -0.78% | -1.64% | ||
| Volume | 2,438,300 | 1,401,600 | 1,178,900 | ||
| 20-Day Average Volume | 2,229,305 | 1,700,345 | 947,860 | ||
| Previous Close | 54.10 | 75.54 | 124.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 53.13 | 75.47 | 118.60 | ||
| 20-Day Raw Stochastic | 59.05% | 45.00% | 68.98% | ||
| 20-Day Relative Strength | 50.18 | 54.07 | 53.08 | ||
| Weighted Alpha | -6.94 | +265.43 | +160.97 | ||
| Today's Opinion | 72% Sell | 88% Buy | 72% Buy | ||
| Previous Opinion | 72% Sell | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 40% Sell | 88% Buy | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.40% since 05/15/26 | -2.24% since 05/15/26 | +6.51% since 05/15/26 | ||
| Low | 49.26 on 05/18/26 | 69.88 on 05/19/26 | 109.93 on 05/19/26 | ||
| High | 55.05 on 05/22/26 | 78.49 on 05/18/26 | 126.41 on 05/21/26 | ||
| 1-Month | |||||
| %Chg | -0.11% since 04/22/26 | +1.39% since 04/22/26 | +5.17% since 04/22/26 | ||
| Low | 49.26 on 05/18/26 | 68.97 on 04/29/26 | 106.00 on 04/29/26 | ||
| High | 57.44 on 05/05/26 | 82.26 on 05/14/26 | 129.18 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | -15.59% since 02/20/26 | +17.86% since 02/20/26 | -6.41% since 02/20/26 | ||
| Low | 49.26 on 05/18/26 | 54.02 on 03/13/26 | 100.15 on 03/30/26 | ||
| High | 66.28 on 02/24/26 | 82.26 on 05/14/26 | 132.92 on 02/23/26 | ||
| 6-Month | |||||
| %Chg | -1.10% since 11/21/25 | +85.29% since 11/21/25 | +2.41% since 11/21/25 | ||
| Low | 49.26 on 05/18/26 | 40.43 on 11/24/25 | 100.15 on 03/30/26 | ||
| High | 66.28 on 02/24/26 | 82.26 on 05/14/26 | 148.83 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,454,731 | 10,557,231 | 9,721,992 | ||
| Shares Outstanding, K | 193,284 | 140,857 | 79,695 | ||
| Annual Sales | 3,221,250,000 | 829,450,000 | 0 | ||
| Annual Net Income | 348,900,000 | -1,630,000 | -380,270,000 | ||
| Last Quarter Sales | 766,210,000 | 73,740,000 | 0 | ||
| Last Quarter Net Income | 105,530,000 | -132,730,000 | -90,870,000 | ||
| 60-Month Beta | 0.23 | 1.28 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.76 on 05/04/26 | -0.93 on 05/07/26 | -1.19 on 03/23/26 | ||
| Earnings Date | 08/03/26 | 08/06/26 | 06/01/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 26.65 | 0.00 | 0.00 | ||